Registry of Toxic Effects of Chemical Substances (RTECS)
2-Furaldehyde
RTECS #
LT7000000CAS #
98-01-1Updated
September 201Molecular Weight
96.09Molecular Formula
C5H4O2Synonyms
2-Formylfuran2-Formylofuran (Polish)
2-Furanaldehyde
2-Furancarbonal
2-Furancarboxaldehyde
2-Furankarbaldehyd (Czech)
2-Furfural
2-Furil-metanale (Italian)
2-Furylaldehyde
2-Furylcarboxaldehyde
2-Furyl-methanal
alpha-Furole
Artificial ant oil
Artificial oil of ants
Fural
Furale
Furfural
Furfural (ACGIH:OSHA)
Furfuraldehyde
Furfurale (Italian)
Furfurol
Furfurole
Furole
NCI-C56177
Pyromucic aldehyde
RCRA waste number U125
Skin and Eye Irritation and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
eye /rabbit | 100 mg/24H | moderate | 85JCAE -,788,1986 |
skin /rabbit | 20 mg/24H | moderate | 85JCAE -,788,1986 |
skin /rabbit | 500 mg/24H | mild | FCTXAV 16,759,1978 |
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
Cytogenetic Analysis | lung/hamster | 1 gm/L | MUREAV 227,117,1989 |
Cytogenetic Analysis | ovary/hamster | 2500 µmol/L | CALEDQ 13,89,1981 |
DNA Damage | mammary gland/human | 150 mg/L/24H (-enzymatic activation step) | MUREAV 588,47,2005 |
DNA inhibition | HeLa cell/human | 3 mmol/L | CRNGDP 13,2389,1992 |
DNA repair | /Bacillus subtilis | 1700 µg/disc | DFSCDX 13,353,1986 |
mutation in mammalian somatic cells | lymphocyte/mouse | 200 mg/L | EMMUEG 11,91,1988 |
mutation in microorganisms | /Salmonella typhimurium | 8094 µg/plate (+/-enzymatic activation step) | MUREAV 58,205,1978 |
other mutation test systems | oral/mouse | 100 mg/kg | MUREAV 343,157,1995 |
other mutation test systems | lung/hamster | 1 gm/L | MUREAV 227,117,1989 |
sex chromosome loss and nondisjunction | parenteral/Drosophila melanogaster | 100 ppm | ENMUDM 7,677,1985 |
sex chromosome loss and nondisjunction | oral/Drosophila melanogaster | 5000 ppm | MUREAV 280,75,1992 |
sex chromosome loss and nondisjunction | intraperitoneal/Drosophila melanogaster | 5000 ppm | MUREAV 280,75,1992 |
sister chromatid exchange | lymphocyte/human | 70 µmol/L | MUREAV 156,233,1985 |
sister chromatid exchange | ovary/hamster | 11700 µg/L | NTPTR* NTP-TR,382,1990 |
specific locus test | oral/Drosophila melanogaster | 5000 ppm | MUREAV 280,75,1992 |
Unscheduled DNA Synthesis | liver/human | 2 nmol/L/24H | FCTOD7 39,999,2001 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/rat | 150 mg/kg (6-15D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | WDZAEK 6,290,1992 |
intraperitoneal/mouse | 360 mg/kg (6D male) | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | WDZAEK 8,129,1994 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/mouse | lowest published toxic dose: 90125 mg/kg/2Y- continuous | Tumorigenic: Carcinogenic by RTECS criteria Liver: Tumors | NTPTR* NTP-TR,382,1990 |
oral/mouse | lowest published toxic dose: 90125 mg/kg/103W- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Liver: Tumors Kidney, Ureter, and Bladder: Kidney tumors | NTIS** PB91-108662 |
oral/mouse | lowest published toxic dose: 90125 mg/kg/103W- intermittent | Tumorigenic: Neoplastic by RTECS criteria Liver: Tumors Kidney, Ureter, and Bladder: Kidney tumors | NTIS** PB91-108662 |
oral/rat | lowest published toxic dose: 30900 mg/kg/103W- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Liver: Angiosarcoma | NTIS** PB91-108662 |
oral/rat | lowest published toxic dose: 30900 mg/kg/2Y- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Liver: Tumors | NTPTR* NTP-TR,382,1990 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/Dog | lethal concentration (50 percent kill): 370 ppm/6H | 34ZIAG -,279,1969 | |
inhalation/human | lowest published toxic concentration: 310 µg/m3 | GISAAA 26(6),3,1961 | |
inhalation/mouse | Lowest published lethal concentration: 370 ppm/6H | 34ZIAG -,279,1969 | |
inhalation/rat | lethal concentration (50 percent kill): 175 ppm/6H | Lung, Thorax, or Respiration: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain | AIHAAP 50,A359,1989 |
inhalation/rat | Lowest published lethal concentration: 640 mg/m3/6H | FCTOD7 42,1389,2004 | |
inhalation/rat | lethal concentration (50 percent kill): 12.2 gm/m3/2H | Lung, Thorax, or Respiration: Respiratory obstruction Vascular: Other changes | TPKVAL 10,35,1968 |
inhalation/rat | Lowest published lethal concentration: 184 mg/kg/3H | FCTOD7 42,1389,2004 | |
intramuscular/rabbit | lethal dose (50 percent kill): 78 mg/kg | FCTXAV 16,759,1978 | |
intraperitoneal/mouse | lethal dose (50 percent kill): 102 mg/kg | FCTXAV 16,759,1978 | |
intraperitoneal/rat | lethal dose (50 percent kill): 20 mg/kg | FCTXAV 16,759,1978 | |
intravenous/Dog | lethal dose (50 percent kill): 250 mg/kg | FCTXAV 16,759,1978 | |
intravenous/mouse | lethal dose (50 percent kill): 152 mg/kg | FCTXAV 16,759,1978 | |
oral/Dog | lethal dose (50 percent kill): 950 mg/kg | Behavioral: Convulsions or effect on seizure threshold Behavioral: Ataxia Gastrointestinal: Nausea or vomiting | 34ZIAG -,279,1969 |
oral/guinea pig | lethal dose (50 percent kill): 541 mg/kg | Liver: Hepatitis (hepatocellular necrosis), zonal Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Blood: Hemorrhage | HYSAAV 32(5),158,1967 |
oral/mouse | lethal dose (50 percent kill): 400 mg/kg | Tumorigenic: Active as anti-cancer agent | BIJOAK 34,1196,1940 |
oral/rabbit | lowest published lethal dose: 800 mg/kg | Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) Eye: Mydriasis (pupilliary dilation) Lung, Thorax, or Respiration: Respiratory stimulation | JPETAB 21,65,1923 |
oral/rat | lethal dose (50 percent kill): 65 mg/kg | BCTKAG 13,371,1980 | |
oral/rat | lowest published lethal dose: 192 mg/kg | FCTOD7 42,1389,2004 | |
parenteral/frog | lowest published lethal dose: 23 gm/kg | JPETAB 21,65,1923 | |
skin/rabbit | lowest published lethal dose: 620 mg/kg | FCTXAV 16,759,1978 | |
subcutaneous/Dog | lethal dose (50 percent kill): 214 mg/kg | FCTXAV 16,759,1978 | |
subcutaneous/guinea pig | lowest published lethal dose: 100 mg/kg | FCTXAV 16,759,1978 | |
subcutaneous/mouse | lethal dose (50 percent kill): 119 mg/kg | FCTXAV 16,759,1978 | |
subcutaneous/rabbit | lowest published lethal dose: 500 mg/kg | HYSAAV 32(5),158,1967 | |
subcutaneous/rat | lethal dose (50 percent kill): 148 mg/kg | Behavioral: Convulsions or effect on seizure threshold | 34ZIAG -,279,1969 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/rat | lowest published toxic concentration: 200 mg/m3/5H/12W- intermittent | Autonomic Nervous System: Sympathomimetic Endocrine: Other changes | BCTKAG 11,403,1978 |
inhalation/rat | lowest published toxic concentration: 10140 µg/m3/24H/60D- continuous | Behavioral: Muscle contraction or spasticity Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | GISAAA 26(6),3,1961 |
inhalation/rat | lowest published toxic concentration: 500 mg/m3/4H/4W- intermittent | Kidney, Ureter, and Bladder: Changes in both tubules and glomeruli | AEHLAU 7,574,1963 |
inhalation/rat | lowest published toxic concentration: 20 mg/m3/6H/28D- intermittent | Olfaction: Other olfaction effects | FCTOD7 42,1389,2004 |
inhalation/rat | lowest published toxic concentration: 80 mg/m3/6H/28D- intermittent | Lung, Thorax, or Respiration: Respiratory depression Liver: Changes in liver weight Endocrine: Changes in spleen weight | FCTOD7 42,1389,2004 |
inhalation/rat | lowest published toxic concentration: 80 mg/m3/6H/28D- intermittent | Lung, Thorax, or Respiration: Respiratory depression | FCTOD7 42,1389,2004 |
inhalation/rat | lowest published toxic concentration: 160 mg/m3/3H/28D- intermittent | Liver: Changes in liver weight | FCTOD7 42,1389,2004 |
inhalation/rat | lowest published toxic concentration: 320 mg/m3/3H/28D- intermittent | Endocrine: Changes in spleen weight | FCTOD7 42,1389,2004 |
inhalation/rat | lowest published toxic concentration: 160 mg/m3/3H/28D- intermittent | Olfaction: Other olfaction effects | FCTOD7 42,1389,2004 |
oral/mouse | lowest published toxic dose: 4800 mg/kg/16D- intermittent | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTPTR* NTP-TR-382,1990 |
oral/mouse | lowest published toxic dose: 4875 mg/kg/13W- intermittent | Liver: Changes in liver weight | NTPTR* NTP-TR-382,1990 |
oral/rat | lowest published toxic dose: 3672 mg/kg/28D- intermittent | Kidney, Ureter, and Bladder: Changes in kidney weight | FCTOD7 42,1389,2004 |
oral/rat | lowest published toxic dose: 768 mg/kg/4D- intermittent | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | FCTOD7 42,1389,2004 |
oral/rat | lowest published toxic dose: 1632 mg/kg/10D- intermittent | Behavioral: Sleep Lung, Thorax, or Respiration: Respiratory depression Lung, Thorax, or Respiration: Other changes | FCTOD7 42,1389,2004 |
oral/rat | lowest published toxic dose: 2688 mg/kg/28D- intermittent | Endocrine: Changes in spleen weight | FCTOD7 42,1389,2004 |
oral/rat | lowest published toxic dose: 4190 mL/kg/17W- continuous | Liver: Hepatitis, fibrous (cirrhosis, post- necrotic scarring) Liver: Other changes Liver: Changes in liver weight | APJAAG 36,1027,1986 |
oral/rat | lowest published toxic dose: 91 mg/kg/14D- intermittent | Liver: Other changes Kidney, Ureter, and Bladder: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes | BCTKAG 15,241,1982 |
subcutaneous/rat | lowest published toxic dose: 75 mg/kg/6W- intermittent | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Blood: Pigmented or nucleated red blood cells Blood: Changes in erythrocyte (RBC) count | AEHLAU 7,574,1963 |
subcutaneous/rat | lowest published toxic dose: 33 mg/kg/13W- intermittent | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Blood: Normocytic anemia Blood: Luekopenia | AEHLAU 7,574,1963 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 2 ppm (skin) | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Confirmed animal carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Limited Evidence | IMEMDT 63,409,1995 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 63,409,1995 |
TOXICOLOGY REVIEW | MUREAV 543,201,2003 | |
TOXICOLOGY REVIEW | MUREAV 564,179,2004 | |
TOXICOLOGY REVIEW | EMMUEG 39,69,2002 | |
TOXICOLOGY REVIEW | ENTOX* -,394,2005 | |
TOXICOLOGY REVIEW | MUREAV 584,1,2005 | |
TOXICOLOGY REVIEW | HUTOX* -,649,1996 | |
TOXICOLOGY REVIEW | TXAPA9 243,180,2010 | |
TOXICOLOGY REVIEW | TXCYAC 286,1,2011 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION | FEREAC 54,7740,1989 | |
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF PESTICIDES | Cancelled | RBREV* -,184,1998 |
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 5 ppm (20 mg/m3) (skin) | DTLVS* 3,120,1971 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-AUSTRALIA | time-weighted average 2 ppm (7.9 mg/m3), JUL2008 | |
Occupational Exposure Limit-AUSTRIA | MAK-TMW 5 ppm (20 mg/m3), skin, 2007 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 2 ppm (8 mg/m3), Skin, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 2 ppm (7.9 mg/m3), skin, carc, MAY2011 | |
Occupational Exposure Limit-FINLAND | time-weighted average 2 ppm (8 mg/m3), short term exposure limit 5 ppm (20 mg/m3), skin, NOV2011 | |
Occupational Exposure Limit-FRANCE | VLE 2 ppm (8 mg/m3), C3 Carcinogen, FEB2006 | |
Occupational Exposure Limit-HUNGARY | time-weighted average 20 mg/m3, Skin, SEP2000 | |
Occupational Exposure Limit-ICELAND | time-weighted average 2 ppm (7.9 mg/m3), skin, NOV2011 | |
Occupational Exposure Limit-JAPAN | Occupational Exposure Limit 2.5 ppm (9.8 mg/m3), skin, MAY2012 | |
Occupational Exposure Limit-KOREA | time-weighted average 2 ppm (8 mg/m3), skin, 2006 | |
Occupational Exposure Limit-MEXICO | time-weighted average 2 ppm (8 mg/m3);short term exposure limit 10 ppm (40 mg/m3) (skin), 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 2 ppm (7.9 mg/m3), skin, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 2 ppm (8 mg/m3), JAN1999 | |
Occupational Exposure Limit-PERU | time-weighted average 2 ppm (7,9 mg/m3), JUL2005 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) 10 mg/m3, MAC(short term exposure limit) 40 mg/m3, JAN1999 | |
Occupational Exposure Limit-RUSSIA | short term exposure limit 10 mg/m3, Skin, JUN2003 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 2 ppm (8 mg/m3);short term exposure limit 5 ppm (20 mg/m3), Skin, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 2 ppm (8 mg/m3), skin, JAN2011 | |
Occupational Exposure Limit-THE NETHERLANDS | MAC-TGG 8 mg/m3, 2003 | |
Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 5 ppm (20 mg/m3), Skin, JAN1993 | |
Occupational Exposure Limit-TURKEY | time-weighted average 5 ppm (20 mg/m3), Skin, JAN1993 | |
Occupational Exposure Limit-UNITED KINGDOM | time-weighted average 2 ppm (8 mg/m3);short term exposure limit 5 ppm (20 mg/m3), skin, OCT2007 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 5 ppm (20 mg/m3) (skin) | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 5 ppm (20 mg/m3) (skin) | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 5 ppm (20 mg/m3) (skin) | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 5 ppm (20 mg/m3) (skin) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Status in Federal Agencies
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division